首页>
外国专利>
NOVEL CLASS OF MONOSPECIFIC AND BISPECIFIC HUMANIZED ANTIBODIES THAT TARGET THE INSULIN-LIKE GROWTH FACTOR TYPE I RECEPTOR (IGF-1R)
NOVEL CLASS OF MONOSPECIFIC AND BISPECIFIC HUMANIZED ANTIBODIES THAT TARGET THE INSULIN-LIKE GROWTH FACTOR TYPE I RECEPTOR (IGF-1R)
展开▼
机译:靶向胰岛素样生长因子I型受体(IGF-1R)的新型单特异性和双特异性人源化抗体
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention concerns a multivalent antibody construct comprising an anti-IGF-1R antibody or antigen-binding fragment thereof, wherein the anti-IGF-1R antibody or antigen-binding fragment thereof comprises the heavy chain variable region complementarity determining region (CDR) sequences CDR1 (DYYMY, SEQ ID NO: 1), CDR2 (YITNYGGSTYYPDTVKG, SEQ ID NO:2) and CDR3 (QSNYDYDGWFAY, SEQ ID NO:3) and the light chain variable region CDR sequences CDR1 (KASQEVGTAVA, SEQ ID NO:4), CDR2 (WASTRHT, SEQ ID NO:5) and CDR3 (QQYSNYPLT, SEQ ID NO:6.
展开▼
机译:本发明涉及包含抗IGF-1R抗体或其抗原结合片段的多价抗体构建体,其中所述抗IGF-1R抗体或其抗原结合片段包含重链可变区互补决定区(CDR)序列CDR1(DYYMY,SEQ ID NO:1),CDR2(YITNYGGSTYYPDTVKG,SEQ ID NO:2)和CDR3(QSNYDYDGWFAY,SEQ ID NO:3)和轻链可变区CDR序列CDR1(KASQEVGTAVA,SEQ ID NO:4) ,CDR2(WASTRHT,SEQ ID NO:5)和CDR3(QQYSNYPLT,SEQ ID NO:6)。
展开▼